These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 14602733

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [Abstract] [Full Text] [Related]

  • 4. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G, Albertsson-Wikland K, Bengtsson BA.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [Abstract] [Full Text] [Related]

  • 5. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
    Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
    [Abstract] [Full Text] [Related]

  • 6. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T, Mulder P, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [Abstract] [Full Text] [Related]

  • 7. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 8. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S, Severi F.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
    Underwood LE, Attie KM, Baptista J, Genentech Collaborative Study Group.
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
    [Abstract] [Full Text] [Related]

  • 11. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.
    Attanasio AF, Howell S, Bates PC, Frewer P, Chipman J, Blum WF, Shalet SM.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3368-72. PubMed ID: 12107251
    [Abstract] [Full Text] [Related]

  • 12. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.
    Li Voon Chong JS, Groves T, Foy P, Wallymahmed ME, MacFarlane IA.
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):175-81. PubMed ID: 11874408
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [Abstract] [Full Text] [Related]

  • 14. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
    Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, Paskova M, Lebl J, Chipman JJ, Shalet SM, Hypopituitary Developmental Outcome Study Group.
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
    [Abstract] [Full Text] [Related]

  • 15. Reevaluation of growth hormone deficiency during and after growth hormone (GH) treatment: diagnostic value of GH tests and IGF-I and IGFBP-3 measurements.
    Darendeliler F, Spinu I, Bas F, Bundak R, Isgüven P, Arslanoğlu I, Saka N, Sükür M, Günöz H.
    J Pediatr Endocrinol Metab; 2004 Jul; 17(7):1007-12. PubMed ID: 15301049
    [Abstract] [Full Text] [Related]

  • 16. Prospective Follow-up of Children with Idiopathic Growth Hormone Deficiency After Termination of Growth Hormone Treatment: Is There Really Need for Treatment at Transition to Adulthood?
    Çamtosun E, Şıklar Z, Berberoğlu M.
    J Clin Res Pediatr Endocrinol; 2018 Jul 31; 10(3):247-255. PubMed ID: 29553045
    [Abstract] [Full Text] [Related]

  • 17. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.
    Vahl N, Juul A, Jørgensen JO, Orskov H, Skakkebaek NE, Christiansen JS.
    J Clin Endocrinol Metab; 2000 May 31; 85(5):1874-81. PubMed ID: 10843168
    [Abstract] [Full Text] [Related]

  • 18. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
    Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM.
    J Clin Endocrinol Metab; 1997 Aug 31; 82(8):2423-8. PubMed ID: 9253311
    [Abstract] [Full Text] [Related]

  • 19. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
    Franco C, Johannsson G, Bengtsson BA, Svensson J.
    J Clin Endocrinol Metab; 2006 Nov 31; 91(11):4408-14. PubMed ID: 16940452
    [Abstract] [Full Text] [Related]

  • 20. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V, Di Biase S, Lettiero T, Labella D, Simeone R, Salerno M.
    Clin Endocrinol (Oxf); 2004 Nov 31; 61(5):607-11. PubMed ID: 15521964
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.